Skip to main content

Table 4 Mean absorbed dose per amount of injected activity (Gy/MBq) for CLB-BAR (present study), CLB-GE (present study), IMR-32 (present study), GOT1, GOT2 and NCI-H69. Data were corrected for decay before estimation of the absorbed dose

From: Neuroblastoma xenograft models demonstrate the therapeutic potential of 177Lu-octreotate

Cell line CLB-BAR
(present study)
CLB-GE
(present study)
IMR-32
(present study)
GOT1 [35] GOT2 [36] NCI-H69 [37]
Activity injected 0.15
MBq
1.5
MBq
15
MBq
0.15
MBq
15
MBq
15
MBq
15
MBq
10
MBq
3.3
MBq
 Adrenals 1.4 0.30 0.096 1.9 0.24 0.15 0.079 0.051
 Blood 0.063 0.029 0.0061 0.14 0.042 0.014 0.00069 0.00056
 Brain 0.090 0.0091 0.0065 0.018 0.011 0.0065
 Kidneys 2.1 2.7 1.3 2.1 1.1 1.4 0.32 0.32
 Liver 0.18 0.067 0.029 0.31 0.052 0.085 0.011 0.0091
 Lungs 1.8 0.46 0.10 4.6 0.26 0.16 0.038
 Spleen 0.22 0.16 0.049 0.54 0.057 0.061 0.012 0.0079
 Tumor 3.6 2.9 0.45 2.4 3.6 1.9 0.27 0.013 0.29